STEQUONA Trademark

Trademark Overview


On Friday, June 11, 2021, a trademark application was filed for STEQUONA with the United States Patent and Trademark Office. The USPTO has given the STEQUONA trademark a serial number of 79316972. The federal status of this trademark filing is REGISTERED as of Tuesday, April 4, 2023. This trademark is owned by NOVARTIS AG. The STEQUONA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
stequona

General Information


Serial Number79316972
Word MarkSTEQUONA
Filing DateFriday, June 11, 2021
Status700 - REGISTERED
Status DateTuesday, April 4, 2023
Registration Number7014514
Registration DateTuesday, April 4, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Translation of Words in MarkThe wording "STEQUONA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events


Event DateEvent Description
Monday, August 7, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 20, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 20, 2023FINAL DISPOSITION PROCESSED
Tuesday, July 4, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 4, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 31, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 11, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 11, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, January 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 15, 2022AMENDMENT FROM APPLICANT ENTERED
Thursday, December 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 5, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, May 31, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, May 31, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, May 31, 2022SUSPENSION LETTER WRITTEN
Thursday, April 28, 2022ASSIGNED TO EXAMINER
Friday, April 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 15, 2021REFUSAL PROCESSED BY IB
Monday, October 25, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, October 25, 2021REFUSAL PROCESSED BY MPU
Wednesday, September 29, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 28, 2021NON-FINAL ACTION WRITTEN
Tuesday, September 28, 2021ASSIGNED TO EXAMINER
Wednesday, September 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 17, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, August 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 7, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sunday, August 1, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB